On Cancer Screening During the COVID-19 Pandemic.
作者信息
Brawley Otis W
机构信息
Department of Oncology, Department of Epidemiology, Johns Hopkins University, Baltimore, MD.
出版信息
J Clin Oncol. 2023 Sep 20;41(27):4338-4340. doi: 10.1200/JCO.23.00284. Epub 2023 Aug 9.
Abstract
摘要
相似文献
1
On Cancer Screening During the COVID-19 Pandemic.关于COVID-19大流行期间的癌症筛查
J Clin Oncol. 2023 Sep 20;41(27):4338-4340. doi: 10.1200/JCO.23.00284. Epub 2023 Aug 9.
2
Cancer screening falls during the COVID-19 pandemic.癌症筛查在新冠疫情期间减少了。
Cancer. 2022 Nov 1;128(21):3755. doi: 10.1002/cncr.34500.
3
Cancer screenings decline significantly during pandemic.在疫情期间，癌症筛查显著减少。
Cancer. 2020 Sep 1;126(17):3894-3895. doi: 10.1002/cncr.33128.
4
Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.新冠疫情首个高峰后癌症筛查检测的恢复情况及可能存在的相关差异。
Cancer Cell. 2021 Aug 9;39(8):1042-1044. doi: 10.1016/j.ccell.2021.06.019. Epub 2021 Jul 1.
5
Impact of COVID-19 on cancer screening: a global perspective.COVID-19 对癌症筛查的影响：全球视角。
Curr Opin Support Palliat Care. 2022 Sep 1;16(3):102-109. doi: 10.1097/SPC.0000000000000602. Epub 2022 Jul 18.
6
The impact of the COVID-19 pandemic on cancer screening.新冠疫情对癌症筛查的影响。
Eur J Cancer Prev. 2022 Sep 1;31(5):487-488. doi: 10.1097/CEJ.0000000000000720. Epub 2021 Aug 26.
7
Creating a healthy community after the pandemic: Reinvigorating routine cancer screening with community support systems.大流行后创建健康社区：通过社区支持系统重振常规癌症筛查。
Cancer. 2021 Dec 1;127(23):4365-4367. doi: 10.1002/cncr.33858. Epub 2021 Aug 26.
8
Re-engaging EU citizens with national screening programmes and cancer diagnosis post-pandemic.疫情后重新让欧盟公民参与国家筛查计划和癌症诊断。
Lancet Oncol. 2022 May;23(5):566-567. doi: 10.1016/S1470-2045(22)00090-0.
9
Routine cancer screening delays due to pandemic at veteran affairs.退伍军人事务部因疫情导致常规癌症筛查延迟。
J Natl Med Assoc. 2022 Feb;114(1):12-15. doi: 10.1016/j.jnma.2021.08.033. Epub 2021 Sep 8.
10
Implementation of Early Detection Services for Cancer in India During COVID-19 Pandemic.印度在 COVID-19 大流行期间实施癌症早期检测服务。
Cancer Control. 2020 Jan-Dec;27(1):1073274820960471. doi: 10.1177/1073274820960471.
引用本文的文献
1
The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States: a retrospective cohort study based on the SEER database.2019冠状病毒病大流行对美国卵巢癌诊断、治疗及预后的影响：一项基于监测、流行病学和最终结果（SEER）数据库的回顾性队列研究
Discov Oncol. 2025 Apr 17;16(1):545. doi: 10.1007/s12672-025-02205-y.
2
Impact of plasma Epstein-Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染后血浆中爱泼斯坦-巴尔病毒DNA对鼻咽癌患者治疗后的影响。
Infect Agent Cancer. 2024 Mar 14;19(1):8. doi: 10.1186/s13027-024-00570-x.
本文引用的文献
1
Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic.美国在 COVID-19 大流行第二年的癌症筛查。
J Clin Oncol. 2023 Sep 20;41(27):4352-4359. doi: 10.1200/JCO.22.02170. Epub 2023 Feb 23.
2
COVID-19 and cancer.新型冠状病毒肺炎与癌症。
Science. 2020 Jun 19;368(6497):1290. doi: 10.1126/science.abd3377.
3
Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity.美国主要癌症风险因素和筛查检测使用的现状：按教育和种族/族裔划分的差异。
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):629-642. doi: 10.1158/1055-9965.EPI-18-1169.
Zotero 插件